tiprankstipranks
Trending News
More News >
Xaar PLC (GB:XAR)
LSE:XAR

Xaar plc (XAR) AI Stock Analysis

Compare
7 Followers

Top Page

GB:XAR

Xaar plc

(LSE:XAR)

Select Model
Select Model
Select Model
Neutral 56 (OpenAI - 4o)
Rating:56Neutral
Price Target:
124.00p
▲(21.57% Upside)
Xaar plc's overall stock score reflects significant challenges in financial performance, with declining revenue and profitability. However, the company's strong equity position and recent positive corporate events, including director share purchases and a positive outlook, provide some optimism. Technical analysis suggests a neutral trend, while valuation remains unattractive due to negative earnings.
Positive Factors
Strong Equity Position
A strong equity position with low leverage provides financial stability, allowing Xaar to withstand market fluctuations and invest in growth opportunities.
Improved Free Cash Flow
Improved free cash flow indicates better cash generation, enhancing Xaar's ability to reinvest in its business and support operational needs.
Innovative Product Offerings
Xaar's focus on innovation in digital inkjet printing positions it well in the industrial printing sector, potentially driving long-term growth and market share expansion.
Negative Factors
Declining Revenue
Declining revenue growth poses a challenge to Xaar's market position and could impact its ability to invest in new technologies and maintain competitive advantages.
Profitability Issues
Ongoing profitability issues may limit Xaar's ability to reinvest in its business, potentially hindering long-term growth and operational efficiency.
Operational Inefficiencies
Operational inefficiencies can lead to increased costs and reduced competitiveness, affecting Xaar's ability to sustain margins and improve profitability over time.

Xaar plc (XAR) vs. iShares MSCI United Kingdom ETF (EWC)

Xaar plc Business Overview & Revenue Model

Company DescriptionXaar plc (XAR) is a leading inkjet technology company based in the United Kingdom, specializing in the development and manufacture of industrial inkjet printing systems. The company operates primarily in the sectors of digital printing and manufacturing, providing high-performance printheads and related technologies. Xaar's core products include a range of piezoelectric inkjet printheads designed for various applications, including ceramics, labels, packaging, and industrial printing. Their innovative solutions enable businesses to enhance productivity and achieve high-quality print results across multiple industries.
How the Company Makes MoneyXaar generates revenue primarily through the sale of its inkjet printheads and associated products, which are sold to manufacturers and businesses in various sectors. Key revenue streams include direct sales of printheads, components, and systems, as well as recurring income from consumables such as inks and maintenance services. The company also engages in partnerships with equipment manufacturers and technology providers to integrate its printheads into broader printing solutions, which can lead to additional revenue opportunities. Xaar's focus on research and development enables it to maintain a competitive edge, continually innovating and expanding its product offerings to meet evolving market demands.

Xaar plc Financial Statement Overview

Summary
Xaar plc faces challenges with declining revenue and profitability, as highlighted by negative profit margins and a negative Return on Equity. However, the company maintains a strong equity position with low leverage, which provides financial stability. The improvement in Free Cash Flow is a positive sign, but overall performance is hindered by ongoing operational inefficiencies and profitability issues.
Income Statement
40
Negative
Xaar plc has experienced declining revenue over the past year, with a Revenue Growth Rate of -13.03%. The Gross Profit Margin stands at 36.18%, which is a decrease from the previous year. The company is struggling with profitability, as evidenced by negative Net Profit Margin and EBIT Margin values of -17.41% and -18.01%, respectively. EBITDA Margin is slightly better at -7.20%, but still negative, indicating challenges in covering operating expenses.
Balance Sheet
65
Positive
The balance sheet shows a solid Equity Ratio of 77.06%, suggesting a strong reliance on equity financing. However, the Return on Equity is negative at -17.19%, reflecting net losses. The Debt-to-Equity Ratio is low at 0.10, indicating low leverage and a conservative capital structure. Despite these strengths, the company’s profitability issues remain a concern.
Cash Flow
55
Neutral
Xaar plc's Free Cash Flow has improved from a negative position last year to a positive Free Cash Flow of 5.58 million. The Operating Cash Flow to Net Income Ratio stands at -0.62, showing a disconnect between reported earnings and cash generation. The Free Cash Flow to Net Income Ratio is favorable at -0.52, indicating some level of efficiency in converting earnings into cash.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue59.98M61.41M70.61M72.78M59.25M47.98M
Gross Profit21.18M22.22M26.89M28.64M20.19M13.01M
EBITDA-6.43M-4.42M3.45M6.03M5.90M288.00K
Net Income-11.19M-10.69M-2.17M1.63M16.22M-11.69M
Balance Sheet
Total Assets74.99M80.69M97.26M102.44M103.94M73.54M
Cash, Cash Equivalents and Short-Term Investments6.79M10.56M9.46M9.06M25.05M18.12M
Total Debt5.34M6.49M10.10M9.21M9.19M2.58M
Total Liabilities16.36M18.50M25.43M30.67M35.14M17.38M
Stockholders Equity58.62M62.18M71.83M71.77M68.80M52.39M
Cash Flow
Free Cash Flow589.00K5.58M-2.39M-10.89M-3.97M-3.90M
Operating Cash Flow1.94M6.60M-449.00K-5.50M-2.05M-2.81M
Investing Cash Flow-1.78M-768.00K570.00K-8.63M7.81M-636.00K
Financing Cash Flow-4.08M-4.29M-1.35M-2.92M-674.00K-1.22M

Xaar plc Technical Analysis

Technical Analysis Sentiment
Negative
Last Price102.00
Price Trends
50DMA
119.67
Negative
100DMA
121.76
Negative
200DMA
113.67
Negative
Market Momentum
MACD
-4.66
Positive
RSI
34.00
Neutral
STOCH
19.84
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:XAR, the sentiment is Negative. The current price of 102 is below the 20-day moving average (MA) of 113.80, below the 50-day MA of 119.67, and below the 200-day MA of 113.67, indicating a bearish trend. The MACD of -4.66 indicates Positive momentum. The RSI at 34.00 is Neutral, neither overbought nor oversold. The STOCH value of 19.84 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:XAR.

Xaar plc Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Neutral
£83.66M18.269.34%7.36%31.93%
68
Neutral
£90.93M37.563.88%1.56%8.75%-54.73%
68
Neutral
£106.00M13.8918.63%-3.41%58.10%
67
Neutral
£163.20M43.963.13%2.20%10.66%21.19%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
56
Neutral
£80.60M-7.21-16.64%-7.35%-222.10%
54
Neutral
£200.25M-2.87-31.42%-16.33%-448.12%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:XAR
Xaar plc
102.00
31.00
43.66%
GB:GHH
Gooch & Housego
600.00
112.63
23.11%
GB:SDI
SDI Group
80.00
22.00
37.93%
GB:SOLI
Solid State
160.00
34.54
27.53%
GB:TTG
TT Electronics
112.80
6.30
5.92%
GB:KETL
Strix Group
46.10
1.00
2.22%

Xaar plc Corporate Events

Regulatory Filings and Compliance
Xaar plc Announces Total Voting Rights Update
Neutral
Dec 1, 2025

Xaar plc announced that its issued share capital comprises 79,783,945 ordinary shares, with no shares held in treasury. This announcement is in accordance with the FCA’s Disclosure and Transparency Rules, and the total voting rights figure will be used by shareholders to assess their interests in the company.

Regulatory Filings and Compliance
Xaar plc Announces Lapse of Share Options by COO
Neutral
Nov 24, 2025

Xaar plc announced a transaction involving the lapse of share options under the Xaar 2017 Sharesave Plan by Graham Tweedale, the Chief Operating Officer and Person Discharging Managerial Responsibilities. This transaction, involving 3,857 shares at a price of £1.40 each, was conducted outside a trading venue and reflects the company’s adherence to the UK Market Abuse Regulation, ensuring transparency and regulatory compliance.

Regulatory Filings and Compliance
Xaar plc Announces Total Voting Rights Update
Neutral
Nov 3, 2025

Xaar plc has announced its total voting rights, with the company’s issued share capital consisting of 79,783,945 ordinary shares as of October 31, 2025. This figure is crucial for shareholders to determine their required notifications under the FCA’s Disclosure and Transparency Rules, impacting how stakeholders manage their interests in the company.

Executive/Board ChangesBusiness Operations and Strategy
Xaar plc Grants Share Options to COO Under Sharesave Plan
Neutral
Oct 21, 2025

Xaar plc, a leader in the field of inkjet printing technology, has announced a significant transaction involving its Chief Operating Officer, Graham Tweedale. On 21 October 2025, Tweedale was granted options over 5,673 ordinary shares at a price of £1.068 each under the company’s 2017 Sharesave Plan. This move is part of Xaar’s ongoing efforts to align management interests with shareholder value, potentially impacting the company’s operational focus and market positioning.

Executive/Board ChangesRegulatory Filings and Compliance
Xaar plc Director Purchases Shares Under Regulatory Compliance
Neutral
Oct 2, 2025

Xaar plc announced a transaction involving its Non-Executive Director, Ms. Jacqueline Sutton, who purchased 4,107 ordinary shares at a price of £1.20825 per share. This transaction, conducted in London, is part of the regulatory requirements under the UK Market Abuse Regulation, highlighting the company’s commitment to transparency and compliance.

Regulatory Filings and Compliance
Xaar plc Announces Director’s Share Transaction
Neutral
Oct 2, 2025

Xaar plc, a company involved in the technology sector, announced a transaction involving its Non-Executive Director, Mr. Ben Stocks. The transaction, which took place on October 1, 2025, involved the purchase of 16,114 ordinary shares by Mrs. Sara Stocks, Mr. Stocks’ wife, at a price of £1.285 per share. This transaction was conducted in accordance with the UK Market Abuse Regulation and has been duly notified to the Financial Conduct Authority.

Other
Xaar plc Director Purchases Shares, Signaling Confidence
Positive
Oct 1, 2025

Xaar plc announced a transaction involving Dr. Inken Braunschmidt, a Non-Executive Director, who purchased 4,000 ordinary shares at a price of £1.28 per share. This transaction, compliant with UK Market Abuse Regulation, reflects confidence in the company’s future prospects and may influence stakeholder perceptions positively.

Regulatory Filings and Compliance
Xaar plc Updates Total Voting Rights and Share Capital Structure
Neutral
Oct 1, 2025

Xaar plc announced that its issued share capital comprises 79,767,612 ordinary shares, with no shares held in treasury. This figure is significant for shareholders for calculating their interests under the FCA’s Disclosure and Transparency Rules, impacting how they manage their stakes in the company.

Executive/Board ChangesBusiness Operations and StrategyFinancial Disclosures
Xaar plc Maintains Positive Outlook Amid New Market Opportunities and Tax Liabilities
Positive
Oct 1, 2025

Xaar plc has announced a trading update, maintaining confidence in its financial performance for the year ending 31 December 2025, with new market initiatives progressing as planned. The company has identified historic tax liabilities in an overseas jurisdiction, estimated between £3 million and £4 million, which are not expected to affect future trading. Additionally, Ben Stocks has joined as Chairman and Independent Non-Executive Director, expressing optimism about Xaar’s growth potential.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 07, 2025